Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men - PubMed (original) (raw)

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men

Kitt Falk Petersen et al. Proc Natl Acad Sci U S A. 2006.

Abstract

Type 2 diabetes mellitus (T2DM) is strongly associated with obesity in most, but not all, ethnic groups, suggesting important ethnic differences in disease susceptibility. Although it is clear that insulin resistance plays a major role in the pathogenesis of T2DM and that insulin resistance is strongly associated with increases in hepatic (HTG) and/or intramyocellular lipid content, little is known about the prevalence of insulin resistance and potential differences in intracellular lipid distribution among healthy, young, lean individuals of different ethnic groups. To examine this question, 482 young, lean, healthy, sedentary, nonsmoking Eastern Asians (n = 49), Asian-Indians (n = 59), Blacks (n = 48), Caucasians (n = 292), and Hispanics (n = 34) underwent an oral glucose tolerance test to assess whole-body insulin sensitivity by an insulin sensitivity index. In addition, intramyocellular lipid and HTG contents were measured by using proton magnetic resonance spectroscopy. The prevalence of insulin resistance, defined as the lower quartile of insulin sensitivity index, was approximately 2- to 3-fold higher in the Asian-Indians compared with all other ethnic groups, and this could entirely be attributed to a 3- to 4-fold increased prevalence of insulin resistance in Asian-Indian men. This increased prevalence of insulin resistance in the Asian-Indian men was associated with an approximately 2-fold increase in HTG content and plasma IL-6 concentrations compared with Caucasian men. These data demonstrate important ethnic and gender differences in the pathogenesis of insulin resistance in Asian-Indian men and have important therapeutic implications for treatment of T2DM and for the development of steatosis-related liver disease in this ethnic group.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.

Fig. 1.

Shown are HOMA (a) and ISI (b) distribution in the entire cohort.

Similar articles

Cited by

References

    1. Zimmet P, Alberti KG, Shaw J. Nature. 2001;414:782–787. - PubMed
    1. WHO Expert Consultation. Lancet. 2004;363:157–163. - PubMed
    1. McKeigue PM, Shah B, Marmot MG. Lancet. 1991;337:382–386. - PubMed
    1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Hepatology. 2004;40:1387–1395. - PubMed
    1. King H, Rewers M. Diabetes Care. 1993;16:157–177. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources